Outset Medical
149 hedge funds and large institutions have $721M invested in Outset Medical in 2022 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 58 increasing their positions, 34 reducing their positions, and 35 closing their positions.
344% more call options, than puts
Call options by funds: $9.57M | Put options by funds: $2.15M
71% more repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 34
0.45% less ownership
Funds ownership: 7.21% → 6.76% (-0.45%)
3% less first-time investments, than exits
New positions opened: 34 | Existing positions closed: 35
2% less funds holding
Funds holding: 152 → 149 (-3)
69% less capital invested
Capital invested by funds: $2.33B → $721M (-$1.61B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| 1 |
JP Morgan Chase
New York
|
+$61.4M |
| 2 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$21.5M |
| 3 |
EHI
Eagle Health Investments
Greenwich,
Connecticut
|
+$19.8M |
| 4 |
Barclays
London,
United Kingdom
|
+$17M |
| 5 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
+$15M |
Top Sellers
| 1 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$128M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
-$89.5M |
| 3 |
PA
Perceptive Advisors
New York
|
-$25.4M |
| 4 |
BlackRock
New York
|
-$25.3M |
| 5 |
Allspring Global Investments
Charlotte,
North Carolina
|
-$15.9M |
OM Hedge Fund Activity: Q2 2022 in Review
149 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q2 2022, worth a combined $721M — down 69% from $2.33B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of OM and 34 opened new positions — a net loss of 1 holder — while 34 trimmed existing stakes and 58 added.
The largest buyer was JP Morgan Chase, adding an estimated $61.4M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $128M sold.
- 149 institutional investors held Outset Medical (OM) as of Q2 2022, down from 152 in Q1 2022.
- Funds reported $721M of Outset Medical stock for Q2 2022, down 69% quarter-over-quarter.
- 34 funds opened new Outset Medical positions in Q2 2022 and 35 closed out, a net change of -1 holder.
- The largest Outset Medical buyer in Q2 2022 was JP Morgan Chase, an estimated $61.4M added.
- The largest Outset Medical seller in Q2 2022 was PFM Health Sciences, an estimated $128M sold.
Based on aggregated 13F filings for Q2 2022.